Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use

Investor logo

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

KOVÁCSOVÁ Flóra FOLBER František WEINBERGEROVÁ Barbora ŠTĚPÁNOVÁ Radka KABUT Tomáš TOMÍŠKA Miroslav KREJČÍ Marta MAYER Jiří

Year of publication 2023
Type Article in Periodical
Magazine / Source Annals of hematology
MU Faculty or unit

Faculty of Medicine

Citation
Web https://link.springer.com/article/10.1007/s00277-023-05479-w
Doi http://dx.doi.org/10.1007/s00277-023-05479-w
Keywords Acute and chronic GVHD; AlloHSCT; ATG Grafalon
Attached files
Description Since 2006, combined graft-versus-host disease (GVHD) prophylaxis with ATG Grafalon has been our department's base of peri-transplant supportive care. This recent retrospective study included 398 patients who underwent their first allogeneic hematopoietic stem cell transplantation after receiving a defined dose of ATG Grafalon. Our observations recorded reduced incidence of severe acute and chronic GVHD without negative impact on overall survival in a nonselected group with standard and uniform GVHD prophylaxis.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.